These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 15018878

  • 1. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
    Hermida JS, Tcheng E, Jarry G, Moullart V, Arlot S, Rey JL, Delonca J, Schvartz C.
    Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
    Hermida JS, Jarry G, Tcheng E, Moullart V, Arlot S, Rey JL, Schvartz C.
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744
    [Abstract] [Full Text] [Related]

  • 3. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A, Czepczynski R, Ruchala M, Wasko R, Zgorzalewicz-Stachowiak M, Szczepanek E, Zamyslowska H, Bartkowiak Z, Florek E, Sowinski J.
    Neuro Endocrinol Lett; 2009 Mar; 30(2):209-14. PubMed ID: 19675515
    [Abstract] [Full Text] [Related]

  • 4. Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis.
    Hermida JS, Jarry G, Tcheng E, Moullart V, Arlot S, Rey JL, Delonca J, Schvartz C.
    Am J Med; 2004 Mar 01; 116(5):345-8. PubMed ID: 14984821
    [No Abstract] [Full Text] [Related]

  • 5. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R, Fica S, Barbu C, Vârtej I, Ursu H, Bunghez R, Coculescu M.
    Rom J Intern Med; 2004 Mar 01; 42(3):595-605. PubMed ID: 16366133
    [Abstract] [Full Text] [Related]

  • 6. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.
    Maqdasy S, Batisse-Lignier M, Auclair C, Desbiez F, Citron B, Thieblot P, Roche B, Lusson JR, Tauveron I.
    Am J Cardiol; 2016 Apr 01; 117(7):1112-6. PubMed ID: 26853955
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis.
    Wang M, Cai S, Sun L, Zhao Q, Feng W.
    Cardiol J; 2016 Apr 01; 23(4):416-21. PubMed ID: 27296156
    [Abstract] [Full Text] [Related]

  • 8. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jun 01; 95(6):2529-35. PubMed ID: 20525904
    [Abstract] [Full Text] [Related]

  • 9. Treatment of amiodarone-associated thyrotoxicosis.
    Franklyn JA, Gammage MD.
    Nat Clin Pract Endocrinol Metab; 2007 Sep 01; 3(9):662-6. PubMed ID: 17710087
    [Abstract] [Full Text] [Related]

  • 10. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N, Dietlein M, Caglayan E, Erdmann E, Er F.
    Dtsch Med Wochenschr; 2010 Apr 01; 135(16):807-11. PubMed ID: 20391312
    [Abstract] [Full Text] [Related]

  • 11. [Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture].
    Henzen C, Buess M, Brander L.
    Schweiz Med Wochenschr; 1999 May 01; 129(17):658-64. PubMed ID: 10407936
    [Abstract] [Full Text] [Related]

  • 12. [Long-term preventive effect and safety of amiodarone in patients with paroxysmal atrial fibrillation refractory to class I antiarrhythmic agents: analysis based on patient profiles].
    Komatsu T, Horiuchi D, Nakamura S, Suzuki O, Yomogida K, Okumura K.
    J Cardiol; 2005 Jan 01; 45(1):11-7. PubMed ID: 15700925
    [Abstract] [Full Text] [Related]

  • 13. [Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].
    Gómez JJ, Pomar MD, Casariego AV, Rodríguez IC.
    Endocrinol Nutr; 2009 Oct 01; 56(8):418-21. PubMed ID: 19959152
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
    Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L.
    Clin Endocrinol (Oxf); 2008 Nov 01; 69(5):812-8. PubMed ID: 18410546
    [Abstract] [Full Text] [Related]

  • 15. Amiodarone-induced thyrotoxicosis. A review.
    Piga M, Serra A, Boi F, Tanda ML, Martino E, Mariotti S.
    Minerva Endocrinol; 2008 Sep 01; 33(3):213-28. PubMed ID: 18846027
    [Abstract] [Full Text] [Related]

  • 16. Amiodarone-induced thyrotoxicosis in a case of Eisenmenger's syndrome.
    Czarnywojtek A, Woliński K, Waśko R, Florek E, Zgorzalewicz-Stachowiak M, Fichna M, Greberska W, Guzik P, Lodyga M, Kwiecinska B, Ruchała M.
    Neuro Endocrinol Lett; 2013 Sep 01; 34(8):767-72. PubMed ID: 24522013
    [Abstract] [Full Text] [Related]

  • 17. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
    Bucerius J, Ezziddin S, Brockmann H, Palmedo H, Biersack HJ.
    Exp Clin Endocrinol Diabetes; 2007 Oct 01; 115(9):606-9. PubMed ID: 17943696
    [Abstract] [Full Text] [Related]

  • 18. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
    Liang YL, Huang SM, Peng SL, Hsiao SH, Hung HC, Ou HY, Wu TJ.
    Ann Pharmacother; 2009 Jan 01; 43(1):134-8. PubMed ID: 19109209
    [Abstract] [Full Text] [Related]

  • 19. Amiodarone-induced thyroid dysfunction in clinical practice.
    Ursella S, Testa A, Mazzone M, Gentiloni Silveri N.
    Eur Rev Med Pharmacol Sci; 2006 Jan 01; 10(5):269-78. PubMed ID: 17121321
    [Abstract] [Full Text] [Related]

  • 20. Therapy-resistant ventricular tachycardia caused by amiodarone-induced thyrotoxicosis: a case report of electrical storm.
    Erdogan HI, Gul EE, Gok H, Nikus KC.
    Am J Emerg Med; 2012 Nov 01; 30(9):2092.e5-7. PubMed ID: 22386340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.